ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
676
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
312 A Novel Assay for the Met Inhibitory Activity of MGCD265 in Plasma From Solid Tumor Patients in a Dose Escalating Phase I Study
Author(s):
M Fournel
,
J. Wang
,
N Beaulieu
,
C. BONFILS.
,
H. HURWITZ
,
G Shapiro
,
C.K. Kollmannsberger
,
M Juretić
,
J.M. Besterman
,
C.R. Maroun
Publication date:
2012
Journal:
European Journal of Cancer
Read this article at
ScienceOpen
Publisher
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Fandom activity
Author and article information
Journal
DOI::
10.1016/S0959-8049(12)72110-X
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
676
The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis
Authors:
C. BONFILS.
,
N Beaulieu
,
M Fournel
…
Potent preclinical antitumor activity of MGCD265, an oral Met/VEGFR kinase inhinitor inphase II clinical development, in combinationwith taxanes of erlotinib
Authors:
Phase I study of daily administration of MGCD265 to patients with advanced malignancies (Study 265–101)
Authors:
CK Kollmannsberger
,
H Hurwitz
,
G Vlahovic
…
See all similar
Cited by
1
AXL kinase inhibitors- A prospective model for medicinal chemistry strategies in anticancer drug discovery
Authors:
Chinmay Malvankar
,
Dileep Kumar
See all cited by